With the recent ability to incorporate artificial intelligence (AI) and machine learning (ML) into life sciences products for human health, founders may not be aware of their position regarding protecting their intellectual property (IP). Attorney Jason Novak, Partner at Norton Rose Fulbright, will walk founders through the potential IP considerations for life sciences companies developing products for human health. Register on Eventbrite.